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were found to be associated with infection-induced asthma 
[p = 0.0009, OR (95% CI) = 0.5 (0.4–0.8)]. The rs487202–
rs574913 CA haplotype was more frequent among patients 
with infection-induced asthma [p = 0.0006, OR (95% CI) = 1.9 
(1.3–2.6)]. None of the SNPs contributed directly to the risk of 
asthma.  Conclusions: Our results suggest that genetic varia-
tion in the  HRH4 gene might influence the pathogenesis of 
infection-induced asthma.  Copyright © 2012 S. Karger AG, Basel 
 Introduction 
 Asthma is a highly prevalent chronic inflammatory 
disease of the airways worldwide. This complex syn-
drome is characterized by variable and recurring symp-
toms including reversible airflow obstruction, broncho-
spasm, airway hyperresponsiveness and chronic inflam-
mation of the airways. Clinically it is diagnosed on the 
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 Abstract 
 Background: Histamine as an inflammatory mediator plays 
an important role in chronic allergic and asthmatic condi-
tions. However, the role of genetic polymorphisms of the 
 histamine receptor  HRH4 (histamine receptor H4) gene in 
asthma susceptibility and endophenotypes has not been 
studied yet. Our aim was to investigate the possible associa-
tion between single nucleotide polymorphisms (SNPs) in the 
 HRH4 gene and asthma or some endophenotypes of asthma. 
 Methods: Twenty-one SNPs of the  HRH4 gene were geno-
typed in 313 asthmatic patients and 360 controls using 
 Sequenom  iPLEX  Gold Genotyping Technology.  Results: 
Genotype distribution of three  HRH4 SNPs, namely
rs17187619 [p = 0.002; odds ratio, OR (95% confidence inter-
val, CI) = 2.4 (4.1–1.4)], rs527790 [p = 0.0002; OR (95% CI) = 3.3 
(6.1–1.8)] and rs487202 [p = 0.00007; OR (95% CI) = 3.5 
 (6.6–1.9)] differed significantly between patients with or 
without in fection-induced asthma. Haplotypes, which 
 included the rs4800573–rs527790 CC allele combination, 
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basis of the symptoms of wheeze, dyspnea, cough, chest 
tightness and shortness of breath.
 Asthma is a multifactorial disease with genetic, envi-
ronmental, allergic, infectious, nutritional and emotional 
components contributing to its inception and evolution. 
The complexity of the disease originates from the above-
mentioned factors. Recent genetic studies suggest the role 
of an unknown number of genes with moderate effects in 
the pathomechanism of asthma  [1] .
 Asthma can be manifested in different phenotypes. 
These phenotype categories can be defined by clinical 
and physiological criteria, and by environmental triggers 
and their pathobiology. The most common phenotype in 
children is allergic asthma, triggered by an allergic sensi-
tization associated with the presence of a specific IgE  [2] . 
Allergen-induced asthma can be categorized by certain 
features such as allergy of one or more environmental 
antigens (mono/poly) or based on the type of allergen: 
inhalative, indoor or outdoor. Non-allergic asthma can 
be caused by anything other than allergens. It may be 
triggered by inhalation of chemicals such as cigarette 
smoke or cleaning agents, taking aspirin, a chest infec-
tion, stress, laughter, cold air, food preservatives or a myr-
iad of other factors. Exercise can also induce an asthma 
attack in people who have no other triggers and do not 
experience asthma under any other circumstances. Re-
spiratory infections provoked by bacteria or viruses can 
also trigger asthma (called infection-induced asthma). 
Asthma can frequently occur together with other allergic 
diseases, such as allergic rhinitis or conjunctivitis, with 
confirmed links between these diseases  [3] .
 Histamine is known to be an inflammatory mediator 
which contributes to the progression of allergic-inflam-
matory responses by enhancement of the secretion of 
proinflammatory cytokines and chemokines  [4] . A vari-
ety of physiological and pathological functions of hista-
mine are mediated by four different receptors: HRH1, 
HRH2, HRH3 and HRH4 (histamine receptor H1–4), 
among which types 1, 2 and 4 have been proven to affect 
inflammation and other immune processes and have 
been proposed as useful targets for the treatment of im-
mune and inflammatory diseases  [5, 6] .
 HRH4, similarly to all other histamine receptors, is a 
constitutively active, G protein-coupled molecule ex-
pressed mainly on immune cells, including mast cells, 
monocytes, eosinophils, basophils, dendritic cells, T cells 
and natural killer cells  [7, 8] . However, it was recently 
demonstrated that HRH4 was functionally expressed on 
neurons in the mammalian central nervous system  [9] .
 HRH4 is considered to have a role in a number of in-
flammatory disorders such as allergy, asthma, chronic 
pruritus and autoimmune diseases  [10] . HRH4 ligands 
have shown efficacy in dampening airway inflammation 
and reducing asthma-like symptoms, although the exact 
mechanism of this function is unknown  [11] . Adminis-
tration of an HRH4 antagonist (JNJ7777120) to HRH4 
genetically deficient animals has been demonstrated to 
diminish asthma-like parameters  [12] . Interestingly, 
treatment with the HRH4 agonist 4-methylhistamine re-
sulted in mitigation of airway hyperreactivity and in-
flammation  [13] . Based on these studies HRH4 may me-
diate pro- or anti-inflammatory signals in asthmatic con-
ditions and on the whole ligands for this histamine 
receptor may prove beneficial for the relief of asthma 
symptoms and could become effective therapeutic tools 
in the future.
 Although genetic polymorphisms can alter gene ex-
pression or receptor functions, there have so far only been 
two studies about genetic variations in the HRH4 gene 
 [14, 15] . In our study we investigated whether  HRH4 gene 
polymorphisms might play a role in asthma progression 
or influence some phenotype categories of the disease.
 Materials and Methods 
 Patients 
 The 313 children analyzed in this study were of Hungarian 
(Caucasian) origin and diagnosed with asthma bronchiale by spe-
cialist physicians based on the following characteristics: (1) recur-
rent breathlessness and expiratory dyspnea requiring treatment; 
(2) wheeze; (3) reversibility of wheezing and dyspnea by broncho-
dilator treatment measured as forced expiratory volume 1s (FEV 1 ) 
by a spirometer. The asthmatic cohort consisted of 203 male and 
110 female patients with a mean age at diagnosis of 10.5 years. The 
characteristics of the study population are shown in  table 1 . Clin-
ical data of the patients were collected using a questionnaire based 
on ISAAC (International Study of Asthma and Allergies in Child-
hood) questionnaires (http://isaac.auckland.ac.nz/) completed by 
the physician together with the parents of the patients. We ana-
lyzed the clinical data of the patients regarding the endopheno-
types of asthma. Characterization of the patients was based on the 
decision of a specialist physician.
 The control group was composed of 360 subjects (181 males, 
179 females, mean age 21.7 years), and were healthy adult blood 
donors from the Hungarian National Blood Transfusion Service 
and minor outpatients from either the Orthopedic Department of 
the Budai Children’s Hospital or the Urological Department of 
Heim Pal Hospital, Budapest. Clinical data of the controls were 
collected with the same questionnaire as used for the patient 
group. They were of the same ethnicity and geographical region 
as the patients of the asthmatic group and had no history of asth-
ma or other allergic diseases.
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 The study was conducted according to the principles of the 
Declaration of Helsinki, and approved by the Ethics Committee 
of the Hungarian Medical Research Council. Written informed 
consent was obtained from all patients or the parents or guardians 
of the minors involved in the study.
 In our study we analyzed some phenotypes of asthma based 
on the environmental trigger of asthma exacerbation. These were 
the allergen-induced, exercise-induced, infection-induced and 
nonallergic types of asthma. Allergen-induced asthma was de-
fined by certain features such as allergy to one or more environ-
mental antigens (mono/poly) or based on the type of allergen: 
inhalative, indoor or outdoor. Allergy was defined by a skin prick 
test positive for at least one allergen (with wheal diameter 3 mm 
greater than the saline control) and/or positive total or specific 
IgE levels. Serum IgE levels were classified as normal or high ac-
cording to the following age-specific reference ranges (kU/l): 0–1 
year:  ! 15; 1–5 years:  ! 60; 5–10 years:  ! 90, and adult:  ! 100. Exer-
cise-induced asthma was defined on the basis of patients experi-
encing asthma exacerbations in a running test or during any 
physical activity. If the onset of asthma or asthma exacerbations 
were associated with an infection-linked acute respiratory illness, 
the asthma was classified as infection-induced asthma. Non-al-
lergic asthma was diagnosed in cases where an asthmatic attack 
had no relation to allergen challenge or infection. We also studied 
the expression of other diseases such as allergic rhinitis and al-
lergic conjunctivitis. Rhinitis was defined by troublesome sneez-
ing or blocked or runny nose severely affecting the well-being of 
the patient during periods without a common cold or flu. Only 
those subjects whose rhinitis status was verified by specialists 
were involved in this dataset. Rhinoconjunctivitis-like symptoms 
were defined as an itchy, runny or stuffy nose, or sneezing and/or 
red, burning or weeping eyes occurring at random time points 
almost every day or from time to time, except when occurring 
during a respiratory infection.
 The distinction between mild and moderate asthma and phe-
notypes of asthma was made according to the GINA classification 
(National Institute of Health: Global Strategy for Asthma Man-
agement and Prevention, 2010, http://www.ginasthma.org). Asth-
matic patients could be diagnosed to belong to more than one 
endophenotype category as can be seen in  table 1 .
 Methods 
 Genomic DNA was isolated from peripheral blood using the 
iPrep PureLink gDNA Blood Kit (Invitrogen, Carlsbad, Calif., 
USA) according to the manufacturer’s instructions. Single nucle-
otide polymorphisms (SNPs) of the  HRH4 gene were selected with 
minor allele frequency of more than 9% from the allelic frequen-
cy data of the HapMap database using HapMap Genome Browser 
release No. 27 and the CEU population (CEPH: Utah residents 
with ancestry from northern and western Europe; http://hapmap.
ncbi.nlm.nih.gov/). We covered the whole gene with these SNPs, 
the main features of which are summarized in  table 2 .
Table 1. C haracteristics of the study population








Asthmatics (n = 313) age 10.584.8
gender [male (0)/female (1)] 110 (35) 203 (65)
GINA (no/1/2/3) 68 (22) 52 (17) 168 (54) 25 (8)
Allergen-induced asthma allergy (no/yes) 117 (37) 196 (63)
mono- or poly-allergen [no (0)/
mono (1)/poly (2)]
128 (41) 23 (7) 162 (52)
inhalative allergen (no/yes) 128 (41) 185 (59)
outdoor allergen [no (0)/yes (1)] 166 (53) 147 (47)
indoor allergen [no (0)/yes (1)] 169 (54) 144 (46)
Exercise-induced asthma no (0)/yes (1) 249 (80) 64 (20)
Infection-induced asthma no (0)/yes (1) 224 (72) 89 (28)
Nonallergic asthma no (0)/yes (1) 253 (81) 60 (19)
Other diseases rhinitis [no (0)/yes (1)] 202 (65) 111 (35)
conjunctivitis [no (0)/yes (1)] 253 (81) 60 (19)
Total IgE level normal (0)/high (1) 281.08312.1a 46 (38) 76 (62)
Absolute eosinophil cell count, g/l normal (0)/high (1) 0.480.3b 35 (31) 78 (69)
Eosinophil normal (0)/high (1) 5.484.2c 70 (59) 49 (41)
Controls (n = 360) age 21.7813.9
gender [male (0)/female (1)] 179 (50) 181 (50)
Values in each category are number of patients with percentages in parentheses.
a Measured as kU/l. b Measured as g/l. c Values are percentages.
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 Genotyping 21 of the SNPs was conducted using Sequenom  
iPLEX  Gold Genotyping Technology (Sequenom, San Diego, 
Calif., USA) following the manufacturer’s instructions at the 
McGill University and Génome Québec Innovation Centre 
(Montréal, Qué., Canada). This is a single-base primer extension 
followed by MALDI-TOF MS detection. Samples having SNP call 
rates  ! 80% were excluded from the analysis. Genotyping quality 
control was evaluated through the inclusion of duplicate geno-
typing of one SNP for which  1 99% concordant results were ob-
tained.
 Total serum IgE levels and specific IgE levels of more than 100 
allergens were determined by 3gAllergy blood tests in Immulite 
2000 Immunoassay System (Siemens Healthcare Diagnostics, 
Deerfield, Ill., USA). The eosinophil cell counts were measured by 
Coulter MAXM Analyzer (Beckman Coulter, Krefeld, Germany).
 Statistical Methods 
 The clinical and genotype data were analyzed as dichotomous 
variables. If the number of patients were sufficient (n  6 5) in all 
genotype groups, the analyses were performed using additive (11 
vs. 12 vs. 22), recessive (11/12 vs. 22) or dominant (11 vs. 12/22) 
models, with the common homozygotes signed as 11. Otherwise 
only the dominant model was used. Allele frequencies were cal-
culated by allele counting and tested for deviation with the Hardy-
Weinberg equilibrium by using the online software accessible at 
http://ihg2.helmholtz-muenchen.de/cgi-bin/hw/hwa1.pl. Multi-
ple logistic regression analyses were completed, adjusted for age 
and gender, to assess the effect of the genetic background of asth-
ma development and dichotomous clinical characteristics. Con-
fidence intervals (CI) were calculated at the 95% level. General 
linear model procedures adjusted for age and gender were used to 
analyze the effect of the genetic background on dependent scale 
variables. Linkage disequilibrium (indicated with D’ and r 2 ) and 
estimated haplotype frequency in cases and controls were calcu-
lated by Haploview 4.1 software: http://www.broad.mit.edu/mpg/
haploview/. Haplotype blocks were generated for all the 21 studied 
SNPs of the  HRH4 gene and for 5 SNPs at the 3  end of the studied 
region. Only those haplotypes were included where the difference 
between the haplotype frequencies in the two groups was more 
than 5%. The haplotype-specific odds ratio (OR) was estimated 
using logistic regression.
 Bonferroni correction considering multiple testing for 21 
SNPs was used. Alpha levels of p  ! 0.0024 were considered to be 
significant. Analyses were performed using SPSS 15.0 (SPSS Inc., 
Chicago, Ill., USA) and MedCalc 10.0.2.0 (MedCalc Software, 
Mariakerke, Belgium) programs. The power of the analyses was 
calculated using the Power and Sample Size Calculation 3.0 pro-
gram.
Table 2. C haracteristics of the investigated HRH4 SNPs, and genotype and allele frequencies in the asthmatic and control populations
SNP characteristics Asthma C ontrol













rs17203314 A/G promoter 20291455 221 (71) 76 (24) 8 (3) 0.15 262 (73) 72 (20) 4 (1) 0.12
rs524149 C/T promoter 20292322 258 (82) 44 (14) 5 (2) 0.09 300 (83) 44 (12) 0 (0) 0.06
rs615283 G/A promoter 20294493 217 (69) 73 (23) 13 (4) 0.16 227 (63) 98 (27) 10 (3) 0.18
rs880263 C/T intron 20296661 224 (72) 76 (24) 6 (2) 0.14 265 (74) 76 (21) 3 (1) 0.12
rs1421119 T/C intron 20297288 171 (55) 112 (36) 23 (7) 0.26 193 (54) 134 (37) 17 (5) 0.24
rs623590 C/T intron 20297351 258 (82) 43 (14) 4 (1) 0.08 299 (83) 43 (12) 0 (0) 0.06
rs4483927 T/G intron 20298398 171 (55) 112 (36) 23 (7) 0.26 193 (54) 133 (37) 18 (5) 0.25
rs17797945 C/T intron 20300654 170 (54) 108 (35) 28 (9) 0.27 175 (49) 138 (38) 28 (8) 0.28
rs8088140 C/A intron 20303138 175 (56) 116 (37) 16 (5) 0.24 208 (58) 120 (33) 15 (4) 0.22
rs17187619 T/C intron 20303578 180 (58) 113 (36) 14 (4) 0.23 203 (56) 127 (35) 14 (4) 0.23
rs104000 A/G intron 20305077 225 (72) 73 (23) 9 (3) 0.15 241 (67) 94 (26) 9 (3) 0.16
rs643552 T/C intron 20306557 172 (55) 111 (35) 24 (8) 0.26 195 (54) 126 (35) 23 (6) 0.25
rs657132 G/A intron 20307272 244 (78) 56 (18) 6 (2) 0.11 287 (80) 56 (16) 0 (0) 0.08
rs11665084 C/T A138V 20310764 248 (79) 53 (17) 6 (2) 0.11 288 (80) 52 (14) 4 (1) 0.09
rs11662595 A/G H206R 20310968 246 (79) 54 (17) 6 (2) 0.11 288 (80) 51 (14) 4 (1) 0.09
rs1421125 C/A 3 UTR 20311909 116 (37) 144 (46) 47 (15) 0.39 129 (36) 154 (43) 58 (16) 0.4
rs17797975 T/C 3 UTR 20313366 242 (77) 62 (20) 2 (1) 0.11 275 (76) 60 (17) 2 (1) 0.09
rs4800573 G/A 3 UTR 20313668 236 (75) 61 (19) 9 (3) 0.13 240 (67) 93 (26) 9 (3) 0.16
rs527790 G/A after HRH4 20314913 100 (32) 153 (49) 54 (17) 0.43 125 (35) 160 (44) 58 (16) 0.4
rs487202 C/G after HRH4 20316814 99 (32) 150 (48) 53 (17) 0.42 120 (33) 155 (43) 56 (16) 0.4
rs574913 T/C after HRH4 20317206 245 (78) 55 (18) 6 (2) 0.11 286 (79) 57 (16) 0 (0) 0.08
Ast hma and control values are number of patients with percentages in parentheses. The indicated SNP characteristics are alleles 
(allele 1 and allele 2) with function and position according to the NCBI Genome Build 36.3. The genotype groups are indicated by: 
11 = homozygote for the frequent allele; 12 = heterozygote; 22 = homozygote for the rare allele. MAF = Minor allele frequency.
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 Results 
 Study Population and Allele Frequencies 
 We investigated whether 21 SNPs in the  HRH4 gene 
showed association with asthma or some endopheno-
types of asthma. The characteristics of the study popula-
tion are shown in  table 1 and the minor allelic and geno-
type frequencies are presented in  table 2 . Genotype dis-
tributions were in Hardy-Weinberg equilibrium for all 
SNPs in the population ( table 2 ). The analyses performed 
on the whole population had adequate power (80% for
  = 0.0024) to detect loci with genotype ORs of 1.85 
(MAF = 0.40) ranging to 2.87 (MAF = 0.06). Analyzing 
the subpopulations of asthma patients generated ORs
of 3 (MAF = 0.50) ranging to 5 (MAF = 0.05), which were 
also detectable with adequate power (80% for   = 0.0024).
 By investigating asthma patients we found significant 
correlations between the genotypes and some endophe-
notypes of asthma. Analyses of  HRH4 SNPs among pa-
tients with or without infection-induced asthma showed 
that genotype distribution of three  HRH4 SNPs differed 
in these two groups of patients. The  HRH4 rs487202 GG 
genotype occurred more frequently among patients with 
infection-induced asthma than those without in an ad-
ditive model [28 (33%) vs. 25 (12%), p = 0.0002, OR (95% 
CI) = 3.6 (6.9–1.8)] ( table  3 ). This difference was even 
more pronounced when we compared patients with GG 
genotype to those with at least one C allele (recessive 
model) [28 (33%) vs. 25 (12%), p = 0.00007, OR (95%
CI) = 3.5 (6.6–1.9)] ( table 3 ).
 rs527790 also associated with infection-induced asth-
ma. Patients with infection-induced asthma had more 
rs527790 AA genotype compared to patients without this 
endophenotype of asthma [additive model: 28 (32%) vs. 
26 (12%), p = 0.0004, OR (95% CI) = 3.3 (6.3–1.7); reces-
sive model: 28 (32%) vs. 26 (12%), p = 0.0002, OR (95%
CI) = 3.3 (6.1–1.8)] ( table 3 ).
 We could analyze the rs17187619 only using the dom-
inant model because of the low number of patients with 
the rs17187619 CC genotype. There were fewer patients 
with at least one C allele among the infection-induced 
asthma group compared to patients without infection-
induced asthma [25 (28%) vs. 102 (47%), p = 0.002, OR 
(95% CI) = 2.4 (4.1–1.4)].
 We observed different genotype distributions in three 
 HRH4 SNPs when we compared asthmatic patients with 
or without allergic rhinitis ( table  4 ). Patients with the 
rs1421125 AA genotype suffered more often from allergic 
rhinitis since this genotype was more frequent among pa-
tients with allergic rhinitis than the others in the study 
population [25 (23%) vs. 22 (11%), p = 0.005, OR (95%
CI) = 2.7 (5.6–1.4)]. When we analyzed this SNP under 
the dominant model we could also observe this associa-
tion [CC/CA 25 (23%) vs. AA 22 (11%), p = 0.004, OR (95% 
CI) = 2.5 (4.8–1.3)].
 Genotype distribution was very similar for rs527790 
and rs487202. Among allergic rhinitis patients, 27 (25%) 
carried the rare homozygote genotype rs527790 AA or 
rs487202 GG. Only 27 (14%) or 26 (13%) of asthmatic pa-
tients without allergic rhinitis had the rare homozygote 
genotype [p = 0.006, OR (95% CI) = 2.3 (4.3–1.3) for 
rs527790 and p = 0.006, OR (95% CI) = 2.4 (4.4–1.3) for 
rs487202, respectively].
 Patients with conjunctivitis had less rs615283 GG ge-
notype than patients without this coexisting disease [6 
(10%) vs. 7 (3%), p = 0.008, OR (95% CI) = 4.8 (15.5–1.5)] 
( table 4 ).
 When we used Bonferroni correction for the tests, as-
sociations with p values  1 0.0024 were only nominally 
significant. Therefore, only the association between in-
fection-induced asthma and rs487202, rs527790 and 
rs17187619 can be considered as a true correlation.
 Regarding the similarity of the genotype frequencies 
between rs487202 and rs527790, we calculated the link-
age disequilibrium coefficients for rs487202 and rs527790 
from the genotypes determined in our population. We 
found that these SNPs had a strong linkage disequilibri-
um (D’ = 1.0, r 2 = 0.9;  fig. 1 ).
 The allelic and genotype distributions of asthmatics 
and controls were similar ( table 2 ). There was no differ-
ence between patients with and those without allergy- 
induced asthma, even when we considered the type or 
number of allergens the individuals were sensitive to: 
mono- or poly-allergen, inhalative allergen, outdoor or 
indoor allergen. Patients with exercise-induced or non-
allergic asthma, allergic rhinitis or allergic conjunctivitis 
did not have different allelic or genotype distributions 
compared with patients without this special endopheno-
type of asthma. The distributions of the SNPs did not 
correlate with the severity of asthma (GINA categories), 
IgE level, eosinophil count or eosinophil percentage (data 
not shown).
 Haplotype Analysis 
 To ascertain whether haplotype blocks rather than 
single SNPs were responsible for the observed associa-
tions between this region and infection-induced asthma, 
we analyzed the haplotype block of 5 SNPs surrounding 
rs487202 and rs527790. We found that certain haplotypes 
were associated with infection-induced asthma ( table 5 ). 
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n p value OR 95% CI 
rs17203314 dominant A/G yes 69 (78) 19 (22) 88 0.2 0.6 1.2–0.4no 152 (70) 65 (30) 217
rs524149 dominant C/T yes 77 (88) 11 (13) 88 0.3 0.7 1.5–0.3no 181 (83) 38 (17) 219
rs615283 dominant G/A yes 58 (67) 29 (33) 87 0.1 1.5 2.6–0.9no 159 (74) 57 (26) 216
rs880263 dominant C/T yes 71 (81) 17 (19) 88 0.1 0.6 1.0–0.3no 153 (70) 65 (30) 218
rs1421119 dominant T/C yes 48 (55) 39 (45) 87 0.6 1.1 1.9–0.7no 123 (56) 96 (44) 219
rs623590 dominant C/T yes 77 (88) 11 (13) 88 0.4 0.7 1.5–0.3no 181 (83) 36 (17) 217
rs4483927 dominant T/G yes 48 (55) 39 (45) 87 0.6 1.1 1.9–0.7no 123 (56) 96 (44) 219
rs17797945 additive C/T yes 48 (55) 28 (32) 12 (14) 88 0.2 1.8 4.1–0.8no 122 (56) 80 (37) 16 (7) 218
rs17797945 dominant C/T yes 48 (55) 40 (45) 88 1.0 1.0 1.7–0.6no 122 (56) 96 (44) 218
rs8088140 additive C/A yes 53 (60) 28 (32) 7 (8) 88 0.2 1.9 5.5–0.7no 122 (56) 88 (40) 9 (4) 219
rs8088140 dominant C/A yes 53 (60) 35 (40) 88 0.5 0.8 1.4–0.5no 122 (56) 97 (44) 219
rs17187619 dominant T/C yes 63 (72) 25 (28) 88 0.002 2.4 4.1–1.4no 117 (53) 102 (47) 219
rs104000 dominant A/G yes 67 (76) 21 (24) 88 0.5 0.8 1.5–0.5no 158 (72) 61 (28) 219
rs643552 additive T/C yes 54 (61) 29 (33) 5 (6) 88 0.3 0.6 1.7–0.2no 118 (54) 82 (37) 19 (9) 219
rs643552 dominant T/C yes 54 (61) 34 (39) 88 0.3 0.7 1.2–0.4no 118 (54) 101 (46) 219
rs657132 dominant G/A yes 72 (83) 15 (17) 87 0.5 0.8 1.6–0.4no 172 (79) 47 (21) 219
rs11665084 dominant C/T yes 77 (88) 11 (13) 88 0.1 0.5 1.0–0.2no 171 (78) 48 (22) 219
rs11662595 dominant A/G yes 75 (85) 13 (15) 88 0.2 0.6 1.2–0.3no 171 (78) 47 (22) 218
rs1421125 additive C/A yes 27 (31) 41 (47) 20 (23) 88 0.0 2.4 5.0–1.1no 89 (41) 103 (47) 27 (12) 219
rs1421125 dominant C/A yes 27 (31) 61 (69) 88 0.2 1.5 2.6–0.9no 89 (41) 130 (59) 219
rs1421125 recessive C/A yes 68 (77) 20 (23) 88 0.0 2.1 4.0–1.1no 192 (88) 27 (12) 219
Table 3. G enotype distribution of HRH4 SNPs in patients with or without infection-induced asthma
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n p value OR 95% CI 
rs17797975 dominant T/C yes 64 (73) 24 (27) 88 0.1 1.7 3.1–1.0no 178 (82) 40 (18) 218
rs4800573 dominant G/A yes 68 (77) 20 (23) 88 0.9 1.0 1.9–0.6no 168 (77) 50 (23) 218
rs527790 additive G/A yes 23 (26) 37 (42) 28 (32) 88 0.0004 3.3 6.3–1.7no 77 (35) 116 (53) 26 (12) 219
rs527790 dominant G/A yes 23 (26) 65 (74) 88 0.2 1.4 2.5–0.8no 77 (35) 142 (65) 219
rs527790 recessive G/A yes 60 (68) 28 (32) 88 0.0002 3.3 6.1–1.8no 193 (88) 26 (12) 219
rs487202 additive C/G yes 22 (26) 35 (41) 28 (33) 85
0.0002 3.6 6.9–1.8no 77 (35) 115 (53) 25 (12) 217
rs487202 dominant C/G yes 22 (26) 63 (74) 85 0.2 1.4 2.6–0.8no 77 (35) 140 (65) 217
rs487202 recessive C/G yes 57 (67) 28 (33) 85 0.00007 3.5 6.6–1.9no 192 (88) 25 (12) 217
rs574913 dominant T/C yes 75 (85) 13 (15) 88 0.2 0.7 1.3–0.3no 170 (78) 48 (22) 218
T he genotype distribution of SNPs in the studied populations were compared with logistic regression and the p value, OR and 95% 
CI are indicated. In cases with sufficient patient numbers in all genotype groups (n ≥ 5) the analyses were performed using additive 
(11 vs. 12 vs. 22), recessive (11/12 vs. 22) or dominant (11 vs. 12/22) models, the common homozygote is signed as 11, heterozygote as 
12 and rare homozygote as 22. Otherwise only the dominant model was used. 
Table 3 (continued)
Table 4. G enotype distribution of HRH4 SNPs in patients with or without allergic rhinitis or conjunctivitis
SNP Model Alleles (1/2) Rhinitis Genotype 11 Genotype 12 Genotype 22 n p value OR 95% CI 
rs1421125 additive C/A yes 37 (34) 47 (43) 25 (23) 109 0.005 2.7 5.6–1.4no 79 (40) 97 (49) 22 (11) 198
rs1421125 dominant C/A yes 84 (77) 25 (23) 109 0.004 2.5 4.8–1.3no 176 (89) 22 (11) 198
rs527790 dominant G/A yes 82 (75) 27 (25) 109 0.006 2.3 4.3–1.3no 171 (86) 27 (14) 198
rs487202 dominant C/G yes 82 (75) 27 (25) 109 0.006 2.4 4.4–1.3no 167 (87) 26 (13) 193
SNP Model Alleles (1/2) Conjunctivitis Genotype 11 Genotype 12 Genotype 22 n p value OR 95% CI 
rs615283 additive G/A yes 36 (62) 16 (28) 6 (10) 58 0.008 4.8 15.5–1.5no 181 (74) 57 (23) 7 (3) 245
V alues for each genotype are number of patients with percentages in parentheses. The genotype distribution of SNPs in the studied 
populations were compared with logistic regression, the p value, OR and 95% CI are indicated. In cases with sufficient patient numbers 
in all genotype groups (n ≥ 5) the analyses were performed using additive (11 vs. 12 vs. 22), recessive (11/12 vs. 22) or dominant (11 vs. 
12/22) models, the common homozygote is signed as 11, heterozygote as 12, rare homozygote as 22. Otherwise only the dominant 
model was used.
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Some haplotypes, which included the rs4800573–
rs527790 CC allele combination, were less frequent in in-
fection-induced asthma patients than in other patients 
[chromosomes, n = 60 (34%) vs. n = 214 (49%), p = 0.0009, 
OR (95% CI) = 0.5 (0.4–0.8)]. Interestingly, rs4800573 
alone was not associated with infection-induced asthma. 
This was only the case in haplotype with rs527790, or in 
3–4 SNP-defined haplotype blocks with rs17797975, 
rs527790 and rs487202 ( table 5 ). The rs487202–rs574913 
CA haplotype was more frequent among patients with 
infection-induced asthma [94 (53%) vs. 167 (38%), p = 
0.0006, OR (95% CI) = 1.9 (1.3–2.6)].
 Next, haplotype analysis was performed for all the 21 
studied SNPs of the  HRH4 gene ( table 6 ). We found no 
difference between the asthmatic and control groups. 
However, the frequency of the TGTGCCGGCTAAC-
GATCCTCA haplotype was significantly higher in the 
exercise-induced asthma group than in asthmatic pa-
tients [n = 22 (18%) vs. n = 38 (8%), p = 0.0015, OR (95% 
CI) = 2.5 (1.4–4.4)], indicating that patients with this hap-
lotype might be more susceptible to exercise-induced 
asthma. The other haplotypes did not show a correlation 































































































































































































































































































































































































Block 2 (7 kb) Block 3 (2 kb)
HRH4
3’ UTR
 Fig. 1. Linkage disequilibrium analysis for the 21  HRH4  SNPs in a Hungarian population. Pairwise linkage dis-
equilibrium is expressed as r 2 and D’ (both from 0 to 1). The value of r 2 is indicated by the shade of the boxes 
whereby the more dense shade represents the higher linkage (r 2 = 0 is white, 0  ! r 2  ! 1 are shades of grey and 
r 2 = 1 is black). D’  100 is indicated in the boxes as numbers when D’  ! 1. 
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Table 5.  Haplotype analysis of 2–5 SNPs located in the 3  UTR region or downstream region of HRH4 gene








p value OR 95% CI 
rs17797975 – rs4800573 – rs527790 – rs487202 – rs574913 CCTCA 14% 9% 0.08 1.6 0.9–2.7
rs17797975 – rs4800573 – rs527790 – rs487202 – rs574913 TCCGA 26% 37% 0.01 0.6 0.4–0.9
rs17797975 – rs4800573 – rs527790 – rs487202 – rs574913 TCCGG 8% 12% 0.2 0.6 0.3–1.2
rs17797975 – rs4800573 – rs527790 – rs487202 – rs574913 TCTCA 39% 29% 0.02 1.5 1.1–2.3
rs17797975 – rs4800573 – rs527790 – rs487202 – rs574913 TTCGA 13% 13% 0.9 1 0.6–1.8
rs17797975 – rs4800573 – rs527790 – rs487202 CCTC 14% 9% 0.08 1.6 0.9–2.7
rs17797975 – rs4800573 – rs527790 – rs487202 TCCG 34% 49% 0.0009 0.5 0.4–0.8
rs17797975 – rs4800573 – rs527790 – rs487202 TCTC 39% 29% 0.02 1.5 1.1–2.2
rs17797975 – rs4800573 – rs527790 – rs487202 TTCG 13% 13% 0.9 1 0.6–1.8
rs4800573 – rs527790 – rs487202 – rs574913 CCGA 26% 37% 0.01 0.6 0.4–0.9
rs4800573 – rs527790 – rs487202 – rs574913 CCGG 8% 12% 0.1 0.6 0.3–1.2
rs4800573 – rs527790 – rs487202 – rs574913 CTCA 53% 38% 0.0011 1.8 1.3–2.6
rs4800573 – rs527790 – rs487202 – rs574913 TCGA 13% 13% 0.9 1 0.6–1.8
rs17797975 – rs4800573 – rs527790 CCT 14% 9% 0.08 1.6 0.9–2.7
rs17797975 – rs4800573 – rs527790 TCC 34% 49% 0.0009 0.5 0.4–0.8
rs17797975 – rs4800573 – rs527790 TCT 39% 29% 0.02 1.5 1.1–2.2
rs17797975 – rs4800573 – rs527790 TTC 13% 13% 0.9 1 0.6–1.8
rs4800573 – rs527790 – rs487202 CCG 34% 49% 0.0009 0.5 0.4–0.8
rs4800573 – rs527790 – rs487202 CTC 53% 38% 0.0011 1.8 1.3–2.6
rs4800573 – rs527790 – rs487202 TCG 13% 13% 0.9 1 0.6–1.8
rs527790 – rs487202 – rs574913 CGA 39% 50% 0.02
rs527790 – rs487202 – rs574913 CGG 8% 12% 0.2 0.6 0.3–1.2
rs527790 – rs487202 – rs574913 TCA 53% 38% 0.0011 1.8 1.3–2.6
rs17797975 – rs4800573 TC 73% 78% 0.2 0.8 0.5–1.1
rs17797975 – rs4800573 CC 14% 9% 0.08 1.6 0.9–2.7
rs17797975 – rs4800573 TT 13% 13% 0.9 1 0.6–1.8
rs4800573 – rs527790 CT 53% 38% 0.0011 1.8 1.3–2.6
rs4800573 – rs527790 CC 34% 49% 0.0009 0.5 0.4–0.8
rs4800573 – rs527790 TC 13% 13% 0.9 1 0.6–1.8
rs527790 – rs487202 CG 47% 62% 0.0011 1.8 1.3–2.6
rs527790 – rs487202 TC 53% 38% 0.0011 1.8 1.3–2.6
rs487202 – rs574913 CA 53% 38% 0.0006 1.9 1.3–2.6
rs487202 – rs574913 GA 39% 50% 0.01 0.6 0.4–0.9
rs487202 – rs574913 GG 8% 12% 0.2 0.6 0.3–1.2
H aplotype frequencies determined by rs17797975, rs4800573, rs527790, rs487202 and rs574913 SNPs were compared in patients 
with or without infection-induced asthma. The percentages of the haplotypes were determined by the Haploview 4.1 program. The 
haplotype frequencies were compared with logistic regression and the p value, OR and 95% CI are indicated. Only those haplotypes 
were included where the difference between haplotype frequencies in the two groups was more than 6%.
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 Discussion 
 Histamine is known to have an important role in 
chronic allergic and asthmatic conditions. However, little 
is known about the influence of genetic polymorphisms 
in histamine-associated genes on the development of 
asthma or its endophenotypes.
 In our research we investigated the associations be-
tween 21 SNPs in the  HRH4 gene and asthma or some 
endophenotypes of asthma. We observed that genotype 
distributions were remarkably different in various endo-
phenotypes of asthma. Genotype distributions of three 
 HRH4 SNPs (rs17187619, rs527790 and rs487202) were 
found to differ significantly between patients with or 
without infection-induced asthma. Comparing asthmat-
ic patients with or without allergic rhinitis we observed 
distinct genotype distributions in rs1421125, rs527790 
and rs487202. rs615283 was also associated with conjunc-
tivitis in asthmatics. Additionally, we found that certain 
haplotypes containing rs487202 and rs527790 were asso-
ciated with infection-induced asthma. Haplotype analy-
sis for the 21 SNPs of  HRH4 revealed that TGTGCCG-
GCTAACGATCCTCA was associated with higher sus-
ceptibility to exercise-induced asthma. None of the SNPs 
contributed directly to the risk of asthma.
 It must be noted that this study might have some lim-
itations. Our study population is biased as the patient and 
control groups differ significantly in their age and gen-
der. We think this does not influence our results signifi-
cantly as the adult controls had no history of childhood 
respiratory disease and certainly will not develop child-
hood asthma. Gender may play a role in asthma risk, but 
in this multifactorial disease it could only have a slight 
effect. In addition, whilst this possibility cannot be to-
tally excluded, it seems very implausible that populations 
with the same ethnicity and from the same environment 
would differ significantly in polymorphisms of the  HRH4 
 gene just because of their age and gender. Furthermore, 
in multiple logistic regression analyses we adjusted for 
age and gender, and with this we corrected the possible 
differences caused by these factors. In addition, we car-
ried out corrections for multiple testing in respect of the 
number of SNPs tested. We also carried out the evalua-
tion in multiple subgroups, which could exaggerate the 
significance of our results. But, as detailed previously, 
there is independent evidence in the literature suggesting 
that the  HRH4 gene might play a role in asthma, which 
could be regarded as independent a priori hypotheses 
that strengthen the statistical power of our findings  [16] .
Table 6. H aplotype analysis of the 21 HRH4 SNPs































H aplotype frequencies determined by all studied SNPs in HRH4 gene were compared in the patient populations. The percentages 
of the haplotypes were determined by the Haploview 4.1 program. The haplotype frequencies were compared with logistic regression 
and the p value, OR and 95% CI are indicated. Only those haplotypes are included where the difference between haplotype frequencies 
in the two groups was more than 5%. 
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 The expression pattern of HRH4 suggests its role in 
autoimmune and inflammatory diseases as it is expressed 
on the surface of several cell types playing central roles in 
these disorders, including eosinophils, mast cells, den-
dritic cells or Th2 cells. Indeed, HRH4 is implicated in 
the pathogenesis of colitis, allergy, asthma, pruritus, or 
autoimmune diseases and, due to its proven role in in-
flammatory functions, HRH4 appears to be a promising 
therapeutic target for the treatment of a variety of im-
mune disorders  [10] .
 In vitro and animal studies have shown that signal 
transduction through HRH4 could influence migration, 
cytokine response, mediator release or differentiation of 
these cells  [7] . According to these results it is plausible to 
hypothesize that genetic variations, which might alter the 
expression and/or functions of this receptor, can influ-
ence the pathogenesis of and susceptibility to these dis-
eases.
 To date there has only been two studies in the litera-
ture about SNPs in the HRH4  gene. Yu et al.  [15]  found 
three novel  HRH4 SNPs significantly associated with 
atopic dermatitis. These were rs77485247 (ss142022671), 
rs74604924 (ss142022677) and rs77041280 (ss142022679). 
We did not analyze these SNPs because they were novel 
and therefore not validated by the HapMap project. The 
nearest SNPs studied by us were rs615283 and rs880263 
(close to rs77485247), rs11662595 and rs1421125 (close to 
rs74604924 and rs77041280, which are at adjacent nucle-
otide positions). The genotype distribution of these SNPs 
did not differ between the patient and control popula-
tions. However, we found some associations regarding 
this genomic region, as the rs615283 GG genotype associ-
ated with coexisting conjunctivitis and patients with the 
rs1421125 AA genotype suffered more often from allergic 
rhinitis. The same working group investigated the role of 
these SNPs also in systemic lupus erythematosus, but 
found no association with the development of the disease 
 [14] . They also investigated copy number variations of 
 HRH4 , which they found to increase the risk of systemic 
lupus erythematosus.
 Some observations also indicate the significance of
the relationship between the development of asthma or 
asthma attacks and the presence of histamine. For ex-
ample, ingestion of histamine-rich food may provoke, 
among others, the symptoms of asthma through hista-
mine intolerance  [17] . SNPs in enzymes involved in the 
metabolism of histamine such as HDC (histidine decar-
boxylase), HNMT (histamine N-methyltransferase), 
ABP1 (amil oride binding protein 1, also termed DAO) 
and SLC22A3 solute carrier family 22 (extraneuronal 
monoamine transporter), member 3, also termed OCT3, 
are also described in association with asthma; however, 
the results are contradictory.
 SNP in the  HNMT gene, but not in  ABP1 , significant-
ly influenced the risk of asthma in a Polish population 
 [18] . Polymorphisms in the  HDC and  SLC22A3 genes in-
fluenced the risk of both rhinitis and asthma  [19] . The 
association of asthma with  HNMT SNP could not be ob-
served in two Caucasian (Spanish and German) and an 
Indian population  [20–22] .  HNMT gene polymorphism 
did not influence the endophenotypes of asthma in the 
German group either  [21] . Our results supported these 
findings as we also found no correlation between the risk 
of asthma and the endophenotypes they studied.
 Regarding our findings, it was proven that histamine 
was a key mediator not only in general asthmatic condi-
tions but also in exercise-induced bronchoconstriction or 
in infection-induced asthma. Altogether 5 SNPs in the 
 HRH4 gene (rs615283, rs17187619, rs1421125, rs527790 
and rs487202) were found to influence asthma endophe-
notypes. There is no information about the potential 
function of these SNPs in either HRH4 isoforms. It is 
known that the HRH4 protein has three splice variants 
which code the 390, 302- and 67-amino acid isoforms. 
Among the two exonic SNPs (rs11665084 and rs11662595) 
the rs11665084 is present both in the 390- and 302-amino 
acid isoforms, but rs11662595 is present only in the 
390-amino-acid-long isoform. None of these SNPs are 
present in the 67-amino-acid-long isoform. Nevertheless, 
it is notable that our most important finding was with 
two SNPs (rs527790 and rs487202) downstream of the 
 HRH4 gene. This is an intergenic region, the nearest 
flanking genes of  HRH4  are  IMPACT (upstream) and 
 LOC390843 pseudogene (downstream), however, they do 
not overlap with  HRH4 and are not in linkage disequilib-
rium with it. The localization of these SNPs suggests the 
existence of some possible functional regulatory elements 
in this region.
 This study is the first examining the association of 
 HRH4 SNPs and asthma, although histamine has been 
known to be a relevant molecule for chronic allergic and 
asthmatic conditions for a long time.  HRH4 represents an 
interesting candidate gene for inflammatory immuno-
logical diseases such as asthma due to its predominant 
expression on immune cells and its important role in in-
flammatory and immunological processes. According to 
our results polymorphisms in the  HRH4 gene influence 
some aspects of asthma, further supporting the belief 
that this receptor might play an important role in the dis-
ease.
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 In conclusion, the results gained in this study suggest 
that genetic variation in the  HRH4 gene contributes to the 
pathogenesis of some endophenotypes of asthma. In the 
regulation of allergic diseases such as asthma, targeting 
of HRH4 has already been suggested as a promising new 
therapeutic tool. Further studies are needed to elucidate 
how the results gained in this study fit in the pathomech-
anisms of asthma and asthma endophenotypes. The pre-
cise correlation between nucleotide polymorphisms in 
the genes of histamine receptors or in histamine-metab-
olizing enzymes remains a black hole in our present 
knowledge. Future research on the function of this recep-
tor and information regarding the SNPs of  HRH4 may 
help to identify new candidates for therapeutic targeting 
and enlighten our understanding of the pathogenesis of 
asthma endophenotypes.
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